Product Information

QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.1285 per EA under NDC 00904664261. Its NADAC has been published 464 times since Oct 4, 2017.

FDA first approved this application on Feb 12, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 300 MG TAB

Quetiapine
$0.1285per EA

Strength

300 mg/1

NDC

00904664261

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201504

FDA Approved

2/12/2013

TE Code

AB

On Market Since

3/1/2013

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 464 times since Oct 4, 2017, and over the history we have for it it has declined 49.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1285 per EA
All-time high$0.2588 (Nov 15, 2017)
All-time low$0.1136 (Nov 20, 2024)
52-week high$0.1465
52-week low$0.1265
Median price$0.1565
Average price$0.1649
Largest weekly change-26.7% (Nov 20, 2024)
Weeks tracked464
Tracking sinceOct 4, 2017

Price History

1W

-5.5%

1M

-5.5%

3M

-12.2%

6M

+0.2%

1Y

-11.3%

3Y

-0.4%

5Y

-20.0%

All

-49.2%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Major Pharmaceuticals, is $0.1285 per EA (NDC 00904664261), effective Aug 19, 2026.

How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 49.2%. It has been tracked across 464 weekly CMS publications since Oct 4, 2017.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?

Since Oct 4, 2017, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.2588 (Nov 15, 2017), with a median of $0.1565 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QUETIAPINE FUMARATE 300 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures QUETIAPINE FUMARATE 300 MG TAB?

QUETIAPINE FUMARATE 300 MG TAB (NDC 00904664261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.